Trevi Therapeutics Inc (TRVI) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-1.93x
Trevi Therapeutics Inc (TRVI) has a Cash Flow-to-Debt Ratio of -1.93x as of June 2026, meaning its operating cash flow of $-17.43 Million could theoretically repay -2% of its total liabilities ($9.01 Million) in one year. See financial flexibility index of Trevi Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.93x
Operating CF / Total Liabilities
Operating Cash Flow
$-17.43 Million
USD
Total Liabilities
$9.01 Million
USD
Data as of
Jun 2026
Most recent filing
Trevi Therapeutics Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Trevi Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Trevi Therapeutics Inc.
Annual Cash Flow-to-Debt Ratio for Trevi Therapeutics Inc (2016–2025)
Year-by-year debt coverage analysis for Trevi Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.13x | $-42.09 Million | $10.20 Million | ▼ -21.5% |
| 2024 | -3.40x | $-38.26 Million | $11.26 Million | ▲ +26.5% |
| 2023 | -4.63x | $-31.71 Million | $6.86 Million | ▼ -155.4% |
| 2022 | -1.81x | $-28.18 Million | $15.56 Million | ▼ -33.9% |
| 2021 | -1.35x | $-28.95 Million | $21.40 Million | ▲ +7.4% |
| 2020 | -1.46x | $-29.00 Million | $19.85 Million | ▲ +65.5% |
| 2019 | -4.23x | $-23.09 Million | $5.46 Million | ▲ +26.4% |
| 2018 | -5.75x | $-18.29 Million | $3.18 Million | ▼ -437.0% |
| 2017 | -1.07x | $-7.97 Million | $7.45 Million | ▼ -146.9% |
| 2016 | -0.43x | $-11.19 Million | $25.82 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.